Mike K. Palmer

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis

John R. Crouse, Joel S. Raichlen, Ward A. Riley et al. · JAMA · 2007 · 709 citations

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

Philip J. Barter, Gunnar Brandrup‐Wognsen, Mike K. Palmer et al. · Journal of Lipid Research · 2009 · 257 citations · Full text

Voyager Database, Biochemistry, Medicine +4

Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models

Sanne A. E. Peters, Michiel L. Bots, Hester M. den Ruijter et al. · Journal of Clinical Epidemiology · 2012 · 161 citations

Mixed-effects Models, Time-varying Confounding, Multiple Imputation +5

Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study

John R. Crouse, Diederick E. Grobbee, Daniel H. O’Leary et al. · Cardiovascular Drugs and Therapy · 2004 · 86 citations

Vascular Disease, Subclinical Atherosclerosis—the Rationale, Cardiovascular Epidemiology +12

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study

Christie M. Ballantyne, Ron C. Hoogeveen, Joe L. Raya et al. · Atherosclerosis · 2013 · 46 citations

Cardiovascular Disease, Medicine, Simvastatin 40 +6